AdaptHealth (AHCO) Liabilities and Shareholders Equity (2017 - 2026)
AdaptHealth's (AHCO) quarterly Liabilities and Shareholders Equity came in at $4.4 billion in Q1 2026, little changed year-on-year from $4.4 billion in Q1 2025, and up 2.49% quarter-over-quarter from $4.3 billion in Q4 2025.
AdaptHealth (AHCO) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
AdaptHealth's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $4.4 billion for Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity changed 0.3% year-over-year to $4.4 billion in Q1 2026; TTM through Mar 2026 was $17.5 billion, a 2.4% decrease from a year earlier, with the FY2025 full-year figure at $4.3 billion, down 3.8% from the prior year.
- Liabilities and Shareholders Equity grew to $4.4 billion in Q1 2026 per AHCO's latest filing, from $4.3 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $5.3 billion in Q1 2023 and bottomed at $4.3 billion in Q4 2025.
- The 5-year median for Liabilities and Shareholders Equity is $4.5 billion (2023), against an average of $4.7 billion.
- Across the five-year window, Liabilities and Shareholders Equity advanced 15.14% in 2022 and slipped 14.76% in 2024, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $5.2 billion in 2022, then dropped by 13.62% to $4.5 billion in 2023, then decreased by 0.48% to $4.5 billion in 2024, then dropped by 3.8% to $4.3 billion in 2025, then advanced by 2.49% to $4.4 billion in 2026.
- Per Business Quant, the three latest AHCO Liabilities and Shareholders Equity figures stand at $4.4 billion (Q1 2026), $4.3 billion (Q4 2025), and $4.4 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | 13.32 Bn |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | 37.13 Bn |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 6.63 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 10.46 Bn |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 31.92 Bn |
| 10 | AdaptHealth | 1.49 Bn | 1.45 Bn | 111.50 Mn | 4.42 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.42 Bn |
| Dec 31, 2025 | 4.32 Bn |
| Sep 30, 2025 | 4.38 Bn |
| Jun 30, 2025 | 4.35 Bn |
| Mar 31, 2025 | 4.44 Bn |
| Dec 31, 2024 | 4.49 Bn |
| Sep 30, 2024 | 4.47 Bn |
| Jun 30, 2024 | 4.51 Bn |
| Mar 31, 2024 | 4.50 Bn |
| Dec 31, 2023 | 4.51 Bn |
| Sep 30, 2023 | 4.73 Bn |
| Jun 30, 2023 | 5.20 Bn |
| Mar 31, 2023 | 5.28 Bn |
| Dec 31, 2022 | 5.22 Bn |
| Sep 30, 2022 | 5.24 Bn |
| Jun 30, 2022 | 5.20 Bn |
| Mar 31, 2022 | 5.20 Bn |
| Dec 31, 2021 | 5.25 Bn |
| Sep 30, 2021 | 5.19 Bn |
| Jun 30, 2021 | 4.69 Bn |